World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
99
Citations
41272
World Ranking
1572
National Ranking
882

Overview

James D. Marks is a researcher affiliated with the University of California, San Francisco in the United States. Their work spans multiple disciplines including Medicine and Biochemistry, Genetics and Molecular Biology, with particular focus on Neurology and Molecular Biology among subfields such as Cellular and Molecular Neuroscience and Immunology.

The scientist's research primarily addresses topics related to neurological disorders and treatments, with a specific emphasis on Botulinum Toxin and related neurological disorders. Additional areas of interest include hereditary neurological disorders, Cell Adhesion Molecules Research, TGF-β signaling in diseases, biochemical and structural characterization, and signaling pathways involved in disease mechanisms.

Notable recent papers authored or coauthored by James D. Marks include:

  • Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β, 2020, Cell
  • Dynamic allostery drives autocrine and paracrine TGF-β signaling, 2024, Cell
  • A tumor-specific mechanism of T reg enrichment mediated by the integrin αvβ8, 2021, Science Immunology
  • Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic, 2020, Pharmaceutics
  • A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model, 2021, Toxins

James D. Marks frequently publishes in the following venues:

  • Toxins
  • Cell
  • Science Immunology
  • Pharmaceutics
  • Public Health Reports

The scientist collaborates regularly with several coauthors, including:

  • Jianlong Lou
  • Shauna Farr-Jones
  • Weihua Wen
  • Fraser Conrad
  • Anthony Cormier

Best Publications

  • Methods for producing members of specific binding pairs

    John Mccafferty;Anthony Richard Pope;Kevin Stuart Johnson;Hendricus Renerus Jacobus Mattheus Hoogenboom

  • By-passing immunization: Human antibodies from V-gene libraries displayed on phage

    James D. Marks;Hennie R. Hoogenboom;Timothy P. Bonnert;John McCafferty

  • Production of anti-self antibodies from antibody segment repertoires and displayed on phage

    Andrew David Lilac Court Griffiths;Hendricus Renerus Jacobus Mattheus Hoogenboom;James David Marks;John Mccafferty

  • Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

    Dmitri B. Kirpotin;Daryl C. Drummond;Yi Shao;M. Refaat Shalaby

  • Human anti‐self antibodies with high specificity from phage display libraries.

    A D Griffiths;M Malmqvist;J D Marks;J M Bye

  • Multivalent and multispecific binding proteins, their manufacture and use

    Kaspar-Philipp Holliger;Andrew David Griffiths;Hendricus Renerus Jacobus Matheus Hoogenboom;Magnus Malmqvist

  • By-passing immunization: building high affinity human antibodies by chain shuffling.

    James D. Marks;Andrew D. Griffiths;Magnus Malmqvist;Tim P. Clackson

  • Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

    John W Park;Keelung Hong;Dmitri B Kirpotin;Gail Colbern

  • The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops.

    Ian M. Tomlinson;Gerald Walter;James D. Marks;Meirion B. Llewelyn

  • High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.

    Gregory P. Adams;Robert Schier;Adrian M. McCall;Heidi H. Simmons

  • Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens

    Michael D. Sheets;Peter Amersdorfer;Ricarda Finnern;Peter Sargent

  • Structural repertoire of the human VH segments.

    Cyrus Chothia;Arthur M. Lesk;Ermanno Gherardi;Ian M. Tomlinson

  • Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock.

    J M Luce;A B Montgomery;J D Marks;J Turner

  • Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding Site

    Robert Schier;Adrian McCall;Gregory P. Adams;Keith W. Marshall

  • Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.

    Robert Schier;Jacqueline Bye;Gerald Apell;Adrian McCall

  • Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

    A. Nowakowski;C. Wang;D. B. Powers;P. Amersdorfer

  • Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells

    Christoph Mamot;Daryl C Drummond;Udo Greiser;Keelung Hong

  • Tumor targeting using anti-her2 immunoliposomes

    J.W. Park;D.B. Kirpotin;K. Hong;R. Shalaby

  • Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration

    James D. Marks;Cara Berman Marks;John M. Ljuce;A. Bruce Montgomery

  • Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system.

    J D Marks;H R Hoogenboom;A D Griffiths;G Winter

Frequent Co-Authors

Andrew D. Griffiths
Andrew D. Griffiths PSL University
Leonard A. Smith
Leonard A. Smith United States Department of the Army
Gregory P. Adams
Gregory P. Adams Elucida Oncology
Louis M. Weiner
Louis M. Weiner Georgetown University Medical Center
John W. Park
John W. Park University of California, San Francisco
Christopher C. Benz
Christopher C. Benz Buck Institute for Research on Aging
Greg Winter
Greg Winter University of Cambridge
Keelung Hong
Keelung Hong California Pacific Medical Center
Andrew Bradbury
Andrew Bradbury Los Alamos National Laboratory
Willem H. Ouwehand
Willem H. Ouwehand University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing James D. Marks

Trending Scientists

Recently Published Articles